Indian Pharma Sector Expected To Grow 9-11% In FY22: ICRA

New Delhi :  India’s pharma sector is expected to grow at 9-11% in FY22, rating agency ICRA said on Tuesday.
It attributed the growth to the improving demand for non-Covid products in addition to new product introductions, rupee depreciation, and expanding market coverage.
“Going forward, sustenance of trend in doctor visits and elective surgeries given the news around the Omicron variant, and performance of new launches in addition to revenue growth momentum in the acute segment will remain key monitorables,” ICRA said.
Further, pricing pressures and rising raw material costs are expected to contract margins for the sector to 22.5% in FY22 and further to pre-Covid levels of 21-22% in FY23, said Deepak Jotwani, Assistant Vice President and Sector Head, ICRA.
The outlook for the pharma sector remains ‘Stable’ led by healthy revenue growth and is seen remaining comfortable despite higher capital expenditure and R&D expenses given the robust cash levels.
  • Related Posts

    • Pharma
    • July 24, 2025
    • 299 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 347 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra